Utilizing digital biomarkers to explore risk factors for falls in patients with Lewy Body Dementia
Objective: To analyze risk factors for falls in individuals with Lewy Body Dementia (LBD) enrolled in PRESENCE. Background: PRESENCE was a phase 2 clinical trial…Differential methylation signatures in Lewy body dementia
Objective: This study aimed to compare the DNA methylome of Lewy body dementia (LBD) patients and healthy controls. Background: LBD is the second most common…Evaluating the use of digital biomarkers to test treatment effects on cognition and motor in patients with Lewy Body Dementia
Objective: To evaluate if frequent cognitive and motor tests using an iPad app and a wrist-worn actigraphy watch to track activity and sleep can detect…Can event-related oscillations aid in differentiating Parkinson’s disease and dementia with Lewy bodies?
Objective: To assess the specificity of an EEG signature of the visual event-related oscillations (ERO) in synucleinopathies. Background: Parkinson's disease (PD), PD dementia (PDD) and…Palliative care evaluation for movement disorders during COVID-19: Using Tele neurology to provide real-time care for an at risk Veterans Population.
Objective: To deliver palliative care via telemedicine in a video format to veterans at risk with movement disorders in need of palliative care in the…Long-term cognitive and motor decline across the spectrum of Lewy body disease.
Objective: This study aims to compare the progression of motor and cognitive decline in dementia with Lewy bodies (DLB) compared with Parkinson’s disease (PD) using…Spatiotemporal dynamics in mild cognitive impairment with Lewy bodies
Objective: To explore whether EEG microstate evaluation may help in identifying mild cognitive impairment with Lewy bodies (MCI-LB) and to assess whether the changes correlate…Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies
Objective: To characterize and differentiate gait deficits early on in individuals with DLB and PD. Background: Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD)…Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition
Objective: To examine the impact of Lewy body disease neuropathology (LBD) on domain-specific cognitive impairment in isolation and in combination with Alzheimer’s disease neuropathologic change…Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease
Objective: To compare Neuropsychiatric symptoms (NPS) in participants with Parkinson’s disease (PD), Parkinson’s disease with dementia (PDD), dementia with Lewy bodies (DLB), Alzheimer’s disease (AD)…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 20
- Next Page »